[go: up one dir, main page]

DE1960340A1 - Means to be used by men during sexual intercourse with prophylactic, preventive, antiseptic and / or orthogenic effect and method for its use - Google Patents

Means to be used by men during sexual intercourse with prophylactic, preventive, antiseptic and / or orthogenic effect and method for its use

Info

Publication number
DE1960340A1
DE1960340A1 DE19691960340 DE1960340A DE1960340A1 DE 1960340 A1 DE1960340 A1 DE 1960340A1 DE 19691960340 DE19691960340 DE 19691960340 DE 1960340 A DE1960340 A DE 1960340A DE 1960340 A1 DE1960340 A1 DE 1960340A1
Authority
DE
Germany
Prior art keywords
approximately
layer
mixture
orthogenic
antiseptic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19691960340
Other languages
German (de)
Other versions
DE1960340B2 (en
DE1960340C3 (en
Inventor
Emilio Forti
Giovanni Gazzani
Carlo Del Guercio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PREPHAR PROSPECTION DE RECH S
Prephar Prospection de Recherches Pharmaceutiques
Original Assignee
PREPHAR PROSPECTION DE RECH S
Prephar Prospection de Recherches Pharmaceutiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PREPHAR PROSPECTION DE RECH S, Prephar Prospection de Recherches Pharmaceutiques filed Critical PREPHAR PROSPECTION DE RECH S
Publication of DE1960340A1 publication Critical patent/DE1960340A1/en
Publication of DE1960340B2 publication Critical patent/DE1960340B2/de
Application granted granted Critical
Publication of DE1960340C3 publication Critical patent/DE1960340C3/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/02—Contraceptive devices; Pessaries; Applicators therefor for use by males
    • A61F6/04—Condoms, sheaths or the like, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
  • Moulding By Coating Moulds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Description

rara

Prephar Prospection de Recherches Pharaoeutiques S.A. Schaffhausen (Schweiz)Prephar Prospection de Recherches Pharaoeutiques S.A. Schaffhausen (Switzerland)

"Vom Manne beim Geschlechtsverkehr anzuwendendes Mittel mit prophylaktischer, präventiver, antiseptischer und/oder orthogenischer Wirkung und Methode zu seiner Anwendung""Means to be used by the man during sexual intercourse prophylactic, preventive, antiseptic and / or orthogenic effect and method of its application "

—»—. «—■. ^-— .— .— . I . I —P—l——..— ■— —■-■»!! I II.—— MM — .W.I. I —— —— ■— ^-M — —I —- »-. «- ■. ^ -— .— .—. I. I —P — l ——..— ■ - - ■ - ■ »!! I II .—— MM - .W.I. I —— —— ■ - ^ -M - —I -

—■—»» I I^ ■ — —■ »W-- ■ - »» I I ^ ■ - - ■ »W-

Die Erfindung betrifft ein neues vom Manne beim Geschlechtsverkehr anzuwendendes Mittel mit mechanischer, schützender, präventiver, antiseptischer und/oder orthogenischer Wirkung.The invention relates to a new agent to be used by men during sexual intercourse with a mechanical, protective, preventive, antiseptic and / or orthogenic effect.

Bekannt sind vom Manne anwendbare Mittel. Sie sind als Hülle ausgebildet, die sich der Eichel des männlichen Gliedes anpassen. Sie sind mit einer gallertartigen Substanz versehen, die im reinen Zustand vorliegen oder die das gebräuchliche pharmazeutische Präparat in geeigneter Menge enthalten kann, so daß sie dementsprechend stets eine elastische Beschaffenheit und die Eigenschaft in der Vagina zu schmelzen aufweisen.Means that can be used by man are known. They are designed as sheaths that adapt to the glans of the male member. They are provided with a gelatinous substance which is present in the pure state or which the common pharmaceutical preparation can contain in a suitable amount so that accordingly, they always have an elastic nature and the property of melting in the vagina.

Es stellte sich heraus, daß, wie im folgenden näher beschrieben wird, derartige Hüllen im allgemeinen mit größerer Zuverlässigkeit verwendet werden können, wenn sie eine spezifische Verteilung von spezifisch wirkenden Substanzen und spezifischen Bindemitteln in der inneren und äußeren Sohioht enthalten.It turned out that, as described in more detail below such cases can generally be used with greater reliability if they have a specific Distribution of specific acting substances and specific binding agents contained in the inner and outer Sohioht.

Die erfindungsgemäBen Hüllen bestehen aus einem hUllenförraigen Element von 24 mm Durchmesser, hergestellt aus einer Stärkefolie nach der Art eines Kaohet, wie sie für Hüllen dieser Art allgemein bekannt sind. Diese Stärkefolie hat ein Gewicht von 40 mg. The casings according to the invention consist of a casing-shaped element with a diameter of 24 mm, made from a starch film in the manner of a kaohet, as are generally known for casings of this type. This starch film has a weight of 40 mg.

-2-009830/1100-2-009830 / 1100

Für da· Aulirag»vathHHnlf gilt dl· Gabuhranordnung dar Dautidian Patanianwallikammar.-Garlchliitand fUr Lalitung und Zahlung: Nürnberg.The Dautidian Patanianwallikammar.-Garlchliitand for delivery and payment: Nuremberg applies to the Aulirag »vathHHnlf. Gatprtdia am Fernsprecher haben kein· radiliverblndllcha Wirkung,Gatprtdia on the telephone have no · radiliverblndllcha effect,

" 2" * 19603A0" 2 " * 19603A0

Erfindungsgemäß ist auf der äußeren Oberfläche dieser Hüllen eine Schicht A aufgebracht, mit einem Gesamtgewicht von etwa 18 - 24 mg, die 80 - 90 Gewichtsprozent Polyoxyathylen-sorbitanmonolaurat und 10 - 20 Gewichtsprozent medizinisch wirkender Substanzen enthält. Auf der inneren Oberfläche dieser Hüllen ist eine Schicht B aufgetragen, die ein Gesamtgewicht von etwa " 160 - 200 mg hat, welche ungefähr 80 - 90 Gewichtsprozent einer Mischung aus Bindemitteln und ungefähr 10 - 20 Gewichtsprozent medizinisch wirkender Substanzen enthält.According to the invention, a layer A is applied to the outer surface of these casings, with a total weight of about 18-24 mg, which contains 80-90 percent by weight of polyoxyethylene sorbitan monolaurate and 10-20 percent by weight of medicinally active substances. On the inner surface of these sheaths a layer B is applied, which has a total weight of about " 160-200 mg, which contains about 80-90 percent by weight of a mixture of binders and about 10-20 percent by weight of medicinal substances.

Erfindungsgemäß enthält die Bindemittelmischung in der Schicht B Wasserlösliches Lanolin, Talkum und Polyoxyäthylen-sorbitanmonolaurat. According to the invention, the binder mixture in layer B contains water-soluble lanolin, talc and polyoxyethylene sorbitan monolaurate.

Die Gewichtsverhältnisse liegen ungefähr zwischen 90 * 70 : 4 bis 80 : 60 : 4.The weight ratios are approximately between 90 * 70: 4 until 80: 60: 4.

In beiden Schichten A und B sind die medizinisch wirkenden Substanzen ein Gemisch von Phenylqueeksilbernitrat, Benzyldimethyl-(2-(2-para-l,l,25,3-tetramethylbutyl-phenoxy)-äthoxy)-. äthyl -ammonium chlor id und Paraoxybenzoemethylester, deren relativen Gewischtsverhältnisse im Bereich zwischen 2:4: und >:5: 20 liegen.In both layers A and B are those that have a medicinal effect Substances a mixture of phenylqueekilver nitrate, benzyldimethyl- (2- (2-para-l, l, 25,3-tetramethylbutyl-phenoxy) -ethoxy) -. ethyl ammonium chlorine id and paraoxybenzoemethyl ester, their relative weight ratios in the range between 2: 4: and>: 5:20.

Die erfindungsgemäßen Hüllen bieten einen beträchtlichen Fortschritt gegenüber den bis jetzt bekannten Hüllen.The envelopes of the present invention represent a significant advance compared to the covers known up to now.

Die Kombination der obengenannten medizinisch wirkenden Substanzen sichern eine optimale medizinische Wirkung, während die Beschaffenheit und die Anteile der Bindemittel andere wichtige Vorteile gewährleisten.The combination of the above-mentioned medicinal substances ensure an optimal medicinal effect, while the nature and proportions of the binding agents are other important factors Guarantee benefits.

Insbesondere gewährleistet die äußere Schicht A4 die Polyoxyäthylensorbitan-monolaurat enthält, drei Vorteiles In particular, the outer layer A 4, which contains Polyoxyäthy lensorbitan monolaurate, ensures three advantages

a) einen Teil der medizinisch wirkenden Substanzen in unmittelbaren Kontakt mit den Schleimhäuten zu bringen,a) to bring some of the medicinally active substances into direct contact with the mucous membranes,

-3-009830/1100-3-009830 / 1100

b) das Erweichen der Hülle um einige Sekunden aufzuschieben, die dadurch leichter ihren Bestimmungsort erreichen kann,b) postpone the softening of the envelope for a few seconds, so that it can more easily reach its destination,

c) zu verhindern, daß die Stärkefolie unmittelbar auf Schleimhäuten haftet, wie es bei den gewöhnlichen Kachets der Fall ist.c) to prevent the starch film directly on mucous membranes adheres, as is the case with ordinary kachets.

Die innere Schicht, welche wasserlösliches Lanolin und die übrigen medizinisch wirkenden Substanzen enthält, wirkt noch außerdem als Paste, die der Hülle erlaubt auf der Schleimhaut zu haften, auf der sie angebracht werden soll.The inner layer, which contains water-soluble lanolin and the other medicinal substances, is still effective also as a paste that allows the cover to adhere to the mucous membrane on which it is to be applied.

Das folgende Beispiel soll das Wesen der Erfindung verdeutliehen; ™The following example is intended to illustrate the essence of the invention; ™

Beispielexample

Auf der äußeren Oberfläche der Hüllen, die aus Stärkefolien bestehen und einen Durchmesser von 24 mm (1 Inch) haben, wurde eine Schicht aufgebracht, die ein Gewicht von 20 mg hat und aus einer homogenen Mischung folgender Bestandteile besteht:On the outer surface of the casings, which are made of starch films and 24 mm (1 inch) in diameter applied a layer that has a weight of 20 mg and consists of a homogeneous mixture of the following components:

Polyojxyäthylen-sorbi tan-mono laurat 17 mgPolyojxyethylene sorbi tan mono laurate 17 mg

Medizinisch wirkende Substanzen 3 mgMedicinal substances 3 mg

Auf der inneren Oberfläche der gleichen Hüllen wurde eine Schicht von 180 mg aufgebracht, die aus einer homogenen Mischung der folgenden Bestandteile besteht:On the inner surface of the same covers was a Layer of 180 mg applied, which consists of a homogeneous mixture of the following ingredients:

Wasserlösliches Lanolin 8^,2 mgWater soluble lanolin 8 ^, 2 mg

Talkum 66,0 mgTalc 66.0 mg

Polyoxyäthylen-sorbitan-monolaurat 4,1 mgPolyoxyethylene sorbitan monolaurate 4.1 mg

Medizinisch aktive Substanzen 26,3 mgMedically active substances 26.3 mg

Die medizinisch wirkenden Substanzen in beiden Schichten enthalten der Reihe nach eine Mischung der folgenden Zusammensetzung (in Gewichtsanteilen):The medicinal substances contained in both layers one after the other a mixture of the following composition (in parts by weight):

009830/1100009830/1100

Phenylquecksilbernitrat 2,15 TeilePhenyl mercury nitrate 2.15 parts

Benzyldimethyl-(2-(-para-l,l,5,5-tetramethylbutyl-phenoxy)-äthoxy)-äthyl-ammonium chlorid 4,55 Teile Paraoxybenzoemethylester (Methyl-p-0xybenzoat)25,00 Teile.Benzyldimethyl- (2 - (- para-l, l, 5,5-tetramethylbutyl-phenoxy) -ethoxy) -ethyl-ammonium chloride 4.55 parts paraoxybenzoemethyl ester (methyl p-oxybenzoate) 25.00 parts.

- Ansprüche -- Expectations -

009830/110 0009830/110 0

Claims (2)

AnsprücheExpectations I.JVom Manne beim Geschlechtsverkehr anwendbares Mittel mit mechanischer, prophylaktischer, präventiver, antiseptischer und/oder orthogenischer Wirkung, das aus einer ogivalen Stärkefolie von ungefähr 24 mm.-(I Inch) Durchmesser besteht und auf beiden Oberflächen mit jeweils einer Schicht aus medizinisch wirkenden Substanzen und Bindemitteln versehen ist, dadurch gekennzeichnet, daß auf der äußeren Oberfläche eine Schicht (A) von ungefähr 18 - 24 mg aufgebracht ist, welche aus einer Mischung von 80 - 90 # Polyoxyäthylen-sorbitanmonolaurat und 10 - 20 % medizinisch wirkender Substanzen besteht, und daß auf der inneren Oberfläche eine Schicht (B) von ungefähr I60 - 200 mg angeordnet ist, welche aus einer | Mischung von 80 - 9° # eines Bindemittels, das seinerseits aus der Reihe nach aus wasserlöslichem Lanolin, Talkum und Polyoxyäthylen-sorbitan-monolaurat besteht, und 10 - 20 % medizinisch wirkender Substanzen besteht. IJ Means that can be used by men during sexual intercourse and has a mechanical, prophylactic, preventive, antiseptic and / or orthogenic effect and consists of an ogival thickness film approximately 24 mm and binders, characterized in that a layer (A) of approximately 18-24 mg is applied to the outer surface, which consists of a mixture of 80-90 # polyoxyethylene sorbitan monolaurate and 10-20 % medicinal substances, and that on the inner surface a layer (B) of approximately 160-200 mg is arranged, which consists of a | Mixture of 80 - 9 ° # of a binding agent, which in turn consists of water-soluble lanolin, talc and polyoxyethylene sorbitan monolaurate, and 10 - 20 % medicinal substances. 2. Mittel nach Anspruch 1, dadurch gekennzeichnet, daß die medizinisch wirkenden Substanzen eine Mischung von Phenylquecksilbernitrat, Benzyldimethyl- (2-(2-para-l,l,j5,;S-tetramethylbutyl-phenoxy)-äthoxy)-äfchyl-ammonium chlorid und Methyl-p-Oxybenzoate (Paraoxybenzoemethylester) sind, wobei die relativen Gewichtsverhältnisse zwischen ungefähr 2:4: 20 und ungefähr 5 : 5 : 20 liegen.2. Agent according to claim 1, characterized in that the medicinally active substances are a mixture of phenylmercury nitrate, benzyldimethyl- (2- (2-para-l, l, j5,; S-tetramethylbutyl-phenoxy) -ethoxy) -afchyl-ammonium chloride and methyl p-oxybenzoates (paraoxybenzoemethyl ester), the relative weight ratios being between about 2: 4:20 and about 5: 5:20. J5r Mittel nach den Ansprüchen 1 und 2, dadurch gekennzeichnet, daß die Gewichtsverhältnisse der Bindemittelkomponeten der Schicht B, nämlich wasserlösliches Lanolin, Talkum und Polyoxyäthylen-sorbitan-monolaurat zwischen ungefähr 90 : 70 : und ungefähr 80 : 60 : 4 liegen.J5r Agent according to Claims 1 and 2, characterized in that the weight ratios of the binder components of layer B, namely water-soluble lanolin, talc and polyoxyethylene sorbitan monolaurate, are between approximately 90: 70: and approximately 80: 60: 4. 00 9 8 30/110000 9 8 30/1100
DE1960340A 1968-12-16 1969-12-02 Means that can be used by the man during sexual intercourse Expired DE1960340C3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25160/68A IT1037007B (en) 1968-12-16 1968-12-16 PRESIDIO FOR MALE USE WITH MECHANICAL PROTECTIVE, PREVENTIVE, ANTISEPTIC AND ORTHOGENIC FUNCTION IN THE FIELD OF SEXUAL RELATIONSHIPS AND MOTORCYCLE FOR ITS APPLICATION

Publications (3)

Publication Number Publication Date
DE1960340A1 true DE1960340A1 (en) 1970-07-23
DE1960340B2 DE1960340B2 (en) 1975-04-10
DE1960340C3 DE1960340C3 (en) 1975-11-20

Family

ID=11215878

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1960340A Expired DE1960340C3 (en) 1968-12-16 1969-12-02 Means that can be used by the man during sexual intercourse

Country Status (16)

Country Link
US (1) US3763861A (en)
JP (1) JPS4841634B1 (en)
AT (1) AT300183B (en)
BR (1) BR6914191D0 (en)
CA (1) CA932660A (en)
CH (1) CH517485A (en)
DE (1) DE1960340C3 (en)
DK (1) DK126019B (en)
FR (1) FR2026205B1 (en)
GB (1) GB1286479A (en)
HU (1) HU165420B (en)
IL (1) IL33298A (en)
IT (1) IT1037007B (en)
NL (1) NL160716C (en)
PL (1) PL80355B1 (en)
TR (1) TR18759A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0079015A1 (en) * 1981-11-06 1983-05-18 Ansell Incorporated Spermacidal condom

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3918443A (en) * 1971-10-20 1975-11-11 Ethyl Corp Method for birth control
JPS4990541U (en) * 1972-11-29 1974-08-06
US4037601A (en) * 1976-04-30 1977-07-26 Denkinger Marian C Process for preparing sterilized feminine hygiene articles of non-woven and woven textures
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
US4198976A (en) * 1977-10-11 1980-04-22 The Procter & Gamble Company Vaginal contraceptive
JPS5498439U (en) * 1977-12-21 1979-07-11
JPS5533236U (en) * 1978-08-24 1980-03-04
JPS573633U (en) * 1980-06-09 1982-01-09
US4381772A (en) * 1980-11-20 1983-05-03 Guistini Fernando G Bioerodible diaphragm
JPS57129056U (en) * 1981-02-07 1982-08-11
GB8416034D0 (en) * 1984-06-22 1984-07-25 Smith Kline French Lab Pharmaceutical dosage unit
US5819742A (en) * 1996-11-06 1998-10-13 Family Health International Vaginal device for preventing conception or the transmission of sexually transmitted diseases, or both

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2467884A (en) * 1944-02-02 1949-04-19 Nathaniel M Elias Spermicides
US2423475A (en) * 1944-07-27 1947-07-08 Claude W Bice Internal surgical dressing
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
US3170464A (en) * 1961-01-26 1965-02-23 Forti Emilio Contraceptive means
FR1407659A (en) * 1963-06-25 1965-08-06 Perfected egg shapes
US3443563A (en) * 1966-08-29 1969-05-13 Atsumi Ishihama Vaginal suppository

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0079015A1 (en) * 1981-11-06 1983-05-18 Ansell Incorporated Spermacidal condom

Also Published As

Publication number Publication date
DK126019B (en) 1973-06-04
CA932660A (en) 1973-08-28
BR6914191D0 (en) 1973-05-08
FR2026205A1 (en) 1970-09-18
IT1037007B (en) 1979-11-10
HU165420B (en) 1974-08-28
FR2026205B1 (en) 1975-02-21
JPS4841634B1 (en) 1973-12-07
CH517485A (en) 1972-01-15
IL33298A (en) 1972-12-29
NL6917532A (en) 1970-06-18
TR18759A (en) 1977-08-10
NL160716C (en) 1979-12-17
US3763861A (en) 1973-10-09
DE1960340B2 (en) 1975-04-10
IL33298A0 (en) 1970-01-29
DE1960340C3 (en) 1975-11-20
GB1286479A (en) 1972-08-23
AT300183B (en) 1972-07-10
PL80355B1 (en) 1975-08-30

Similar Documents

Publication Publication Date Title
DE1960340A1 (en) Means to be used by men during sexual intercourse with prophylactic, preventive, antiseptic and / or orthogenic effect and method for its use
DE2046119C2 (en) Means for treating acne
DE2207294C2 (en) Topical ointment base
DE69122464T2 (en) TRANSDERMAL ABSORBABLE AGENT WITH MORPHINE HYDROCHLORIDE
EP0192640B1 (en) Sucralfate suspension
DE69619052T2 (en) Solid, anhydrous, pharmaceutical preparations for vaginal use
DE2906213C2 (en) Cosmetic and therapeutic cleaning agent
DE1767326A1 (en) Film-forming ointments
DE2441627B2 (en) Skin protection gel
DE2948342A1 (en) METHOD FOR REINFORCING SPROEDER AND / OR BROKEN NAILS, AND COSMETIC MEANS FOR IMPLEMENTING THE METHOD
DE60109945T2 (en) IBUPROFEN SOLUTIONS AS CAPSULE FILLING AND CAPSULE PREPARATIONS
CH634481A5 (en) DITHRANOL CONTAINING AGENT FOR TREATING PSORIASIS.
DE60003175T2 (en) COMBINATION PRODUCT FOR TREATING MALARIA
US4466956A (en) Method of therapy for oral herpes simplex
DE3619426A1 (en) AGENT FOR INCREASING RESISTANCE TO COLD DISEASES IN PATIENTS WITH RESTRICTED LUNG FUNCTION
EP2803354B1 (en) Combination of polyacrylic acid and 2-amino-2-methylpropanol for use in the treatment of Herpes infections
DE3006024A1 (en) TOPICAL, INDOMETHACINE CONTAINING MEDICINAL PRODUCT
DE557608C (en) Process for the production of small intestinal pills and lozenges
DE2945979C2 (en) Medicines used to treat fungal skin diseases and bacterial diseases of the mucous membrane
DE1617306A1 (en) Dentifrices for cleaning teeth and preventing dental diseases such as tooth decay or gingivitis
DE2251197C3 (en) Process for the production of high-dose tablets of tetracycline derivatives
DE3020616A1 (en) COSMETIC PEN MASS WITH ANTIPHLOGISTIC EFFECT
AT124002B (en) Process for the preparation of agents for heartburn.
EP0278997A1 (en) Azapropazone rectal capsules
DE651597C (en) Process for the preparation of durable hormone preparations

Legal Events

Date Code Title Description
SH Request for examination between 03.10.1968 and 22.04.1971
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
8328 Change in the person/name/address of the agent

Free format text: RAU, M., DIPL.-ING. DR.RER.NAT., PAT.-ANW., 8500 NUERNBERG

8339 Ceased/non-payment of the annual fee